Literature DB >> 15078475

Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.

Deha Erdogan1, Bob H M Heijnen, Roelof J Bennink, Mariël Kok, Sander Dinant, Irene H Straatsburg, Dirk J Gouma, Thomas M van Gulik.   

Abstract

BACKGROUND/AIMS: The indocyanine green (ICG) clearance test is the most frequently used test for preoperative assessment of liver parenchymal function but has its limitations. The aim of this study was to investigate the correlation between ICG clearance test and the liver uptake of 99-Technetium-labelled (99mTc)-Mebrofenin (99mTc-Mebrofenin) as measured with hepatobiliary scintigraphy.
METHODS: Fifty-four patients were diagnosed as hepatocellular carcinoma (n=9), hilar tumours (n=20) and 25 patients with non-parenchymal tumours including colorectal metastasis (n=15) and miscellaneous tumours (n=10). One day prior to operation, hepatobiliary 99mTc-Mebrofenin scintigraphy was performed after intravenous injection of 85 MBq and the 15-min clearance rate of ICG (ICG-C15) was measured.
RESULTS: The mean ICG-C15 was 86.86+/-1.19% (SEM). The mean 99mTc-Mebrofenin uptake rate was 12.87+/-0.52%/min. A significant correlation was obtained between 99mTc-Mebrofenin uptake rate by scintigraphy and ICG-C15 (r=0.73, P<0.0001). The mean clearance capacity of the right liver segments (79.83+/-1.63, range 47.75-95.97%) was larger than that of the left segments (20.24+/-1.55, range 6.51-52.51%).
CONCLUSION: 99mTc-Mebrofenin uptake rate as assessed by scintigraphy is an efficient method for determining liver function and correlates well with ICG clearance. At the same time, 99mTc-Mebrofenin scintigraphy provides information of segmental functional liver tissue, which is of additional use when planning liver resection. Copyright Blackwell Munksgaard 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078475     DOI: 10.1111/j.1478-3231.2004.00901.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  33 in total

1.  Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model.

Authors:  Reeta L Veteläinen; Roelof J Bennink; Kora de Bruin; Arlène van Vliet; Thomas M van Gulik
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10       Impact factor: 9.236

2.  Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.

Authors:  Kasia P Cieslak; Roelof J Bennink; Wilmar de Graaf; Krijn P van Lienden; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-07-25       Impact factor: 3.647

3.  Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.

Authors:  Atsushi Hiraoka; Takashi Kumada; Masatoshi Kudo; Masashi Hirooka; Kunihiko Tsuji; Ei Itobayashi; Kazuya Kariyama; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Toshifumi Tada; Hidenori Toyoda; Kazuhiro Nouso; Kouji Joko; Hideki Kawasaki; Yoichi Hiasa; Kojiro Michitaka
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

4.  Liver function declines with increased age.

Authors:  Kasia P Cieslak; Onno Baur; Joanne Verheij; Roelof J Bennink; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-06-20       Impact factor: 3.647

5.  Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.

Authors:  Boris Guiu; François Quenet; Laure Escal; Frédéric Bibeau; Lauranne Piron; Philippe Rouanet; Jean-Michel Fabre; Eric Jacquet; Alban Denys; Pierre-Olivier Kotzki; Daniel Verzilli; Emmanuel Deshayes
Journal:  Eur Radiol       Date:  2017-01-18       Impact factor: 5.315

6.  Imaging-based evaluation of liver function: comparison of ⁹⁹mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI.

Authors:  Dominik Geisel; Lutz Lüdemann; Vera Fröling; Maciej Malinowski; Martin Stockmann; Annekathrin Baron; Bernhard Gebauer; Daniel Seehofer; Vikas Prasad; Timm Denecke
Journal:  Eur Radiol       Date:  2014-12-02       Impact factor: 5.315

Review 7.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.

Authors:  Wilmar de Graaf; Krijn P van Lienden; Sander Dinant; Joris J T H Roelofs; Olivier R C Busch; Dirk J Gouma; Roelof J Bennink; Thomas M van Gulik
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

Review 9.  Optimization of the future remnant liver: review of the current strategies in Europe.

Authors:  Riccardo Memeo; Maria Conticchio; Emmanuel Deshayes; Silvio Nadalin; Astrid Herrero; Boris Guiu; Fabrizio Panaro
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

10.  Role of the ¹³C-methacetin breath test in the assessment of acute liver injury in a rat model.

Authors:  Dong Zhu; Hui Zhang; Jing-Yi Mao; Hong-Yan Wang; Xin Li; You-Qing Xu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.